Ki-67及Bcl-2在骨肉瘤中的表达与化疗疗效的关系

Correlation between Ki-67 and Bcl-2 expression in osteosarcoma and its chemotherapeutic effect

  • 摘要: 目的 探讨Ki-67及Bcl-2在骨肉瘤中的表达与化疗疗效的关系。方法 选取我科2005年9月-2006年12月间化疗前骨肉瘤患者的蜡块标本切片25例,采用EnVision免疫组化方法检测Ki-67及Bcl-2在骨肉瘤中的表达,同时经三疗程大剂量化疗后检测肿瘤坏死率。结果 Ki-67及Bcl-2骨肉瘤中的表达率分别为48%和44%;Ki-67及Bcl-2的表达与肿瘤坏死率之间无统计学差异(P>0.05);Ki-67及Bcl-2在骨肉瘤中的表达有相关性(r=0.6056,P<0.01)。结论 Ki-67和Bcl-2在骨肉瘤的表达具有相关性,但Ki-67及Bcl-2不能作为骨肉瘤化疗效果的指标。

     

    Abstract: Objective To study the correlation between Ki-67 and Bcl-2 expression in osteosarcoma and its chemotherapeutic effect. Methods EnVision immunohistochemistry was used to detect Ki-67 and Bcl-2 expression in 25 osteosarcoma patients admitted to our department in September 2005-December 2006 before chemotherapy. Tumor necrosis rate in these patients was assayed after three courses of large dosage chemotherapy. Results The expression rate of Ki-67 and Bcl-2 in osteosarcoma was 48% and 44%, respectively. No difference was found between Ki-67 and Bcl-2 expression in osteosarcoma and tumor necrosis rate(P>0.05). Ki-67 and Bcl-2 expression in osteosarcoma were correlated(r=0.605 6, P<0.01). Conclusion Ki-67 and Bcl-2 expression in osteosarcoma cannot be used as an index of the chemotherapeutic effect on osteosarcoma although they were correlated.

     

/

返回文章
返回